This grant funds new exploratory research to address critical health and quality-of-life needs for people with Down syndrome, supporting innovative and potentially high-impact studies.
This grant funds innovative, high-impact research projects aiming to transform understanding or treatment of Down syndrome and its related conditions, without requiring preliminary data.
This grant invites researchers to submit biospecimens for omics analysis to study Down syndrome, generating shared data to advance understanding of related health conditions; no direct funding is provided.
NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.